Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

PHASE4CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

February 29, 2012

Conditions
Coronary Artery Disease
Interventions
DRUG

clopidogrel napadisilate + aspirin

clopidogrel napadisilate 75mg + aspirin 100mg

DRUG

clopidogrel bisulfate + aspirin

clopidogrel bisulfate 75mg + aspirin 100mg

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanmi Pharmaceutical co., ltd.

OTHER

lead

Seoul National University Hospital

OTHER